Working with usOur Services
We offer a range of consultancy services for the design, implementation & management of clinical studies to support medical research into Parkinson’s, Alzheimer’s & other neurodegenerative conditions.
Following our extensive experience of clinical studies in medical centres worldwide, including the University of California, San Francisco Medical Centre, National Neuroscience Institute of Singapore and Monash University in Melbourne, we have established a reputation in developing medtech devices and systems. We deliver a range of conventional statistical and innovative machine learning approaches that provide superior monitoring and diagnosis of a whole range of conditions.
WHO WE ARE
Dr Stuart Jamieson
Dr Jamieson has been a Consultant Neurologist at Leeds General Infirmary and Senior Lecturer in Neurology at the University of Leeds for more than twenty years.
He is the senior member of the Yorkshire Movement Disorders Service and has extensive experience and knowledge of Parkinson’s disease, Huntington’s disease, dystonia and tremor managing thousands of patients with these disorders over the years.
Dr Jane Alty
Dr Alty is a Senior Lecturer in Neurology at Wicking Dementia Research & Education Centre at the University of Tasmania.
Her previous role was Consultant Neurologist at Leeds Teaching Hospitals NHS Trust. She is a shareholder in ClearSky MD and was part of the team that won an international award from Hummies (prize money) for work on Parkinson’s dyskinesia.
Regulatory Affairs Counsel
Dr Keith Morris is a registered Member of The Organisation for Professionals in Regulatory Affairs (TOPRA) and holds professional qualifications in Marketing (Chartered Institute of Marketing) & Company Management (Institute of Directors). He also holds a PhD in Biochemistry from the University of Birmingham and a BSc (Hons) in Chemistry with Biochemistry from the University of Leicester.
Dr Michael Lones
Chief Scientific Adviser
Michael is Associate Professor in the School of Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh. His research covers topics in optimisation, data mining, medical informatics, systems biology and non-standard computation. His current work includes the diagnosis and understanding of neurodegenerative diseases, and the use of artificial biochemical networks for controlling robots and other complex systems.
Professor Stephen Smith
Stephen is our Co-Founder and Director and a senior lecturer & academic researcher in the Department of Electronics at the University of York. Stephen’s research has focussed on the diagnosis, differentiation and monitoring of neurodegenerative conditions, such as Parkinson’s and Alzheimer’s. His determination to translate technology from theoretical studies through to widespread clinical adoption has led to collaborations with consultant neurologists and specialist nurses and the development of innovative and unique medical equipment for these conditions.
MAAB, the appointed partner and agent for China, is leading the clinical trials undertaken at leading hospitals in Shanghai, Beijing and other areas of China that support the development of our next generation devices. Anya Zhou, the Project Manager for ClearSky in China, is available for consultations.
Let’s start a conversation